Skip to main content
. 2020 Oct 29;12(11):1038. doi: 10.3390/pharmaceutics12111038

Figure 3.

Figure 3

Nuclear factor kappa-B (NF-κB) activity from LPS-stimulated RAW 264.7 macrophages (1 µg/mL) after 24h treatment with 30 µg/mL and 300 µg/mL of chitosan 70% (A) and 95% (B) DD and viscosity 10 and 3000 mPas and in combination with 30 µg/mL 5-ASA (n = 6; data given as mean ± S.D., * = p < 0.05 compared to 5-ASA 30 μg/mL alone).